VERITY THE POLYCYSTIC OVARIES SELF HELP GROUP
Verity PMOS supports people affected by Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly PCOS. We provide trusted information and peer support, raise awareness, educate healthcare professionals, promote and support research, and work with researchers, policymakers and healthcare organisations to improve understanding, diagnosis, treatment and care.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net expenditure of £1,003 for the year, resulting in a decrease in total funds from £97,403 to £96,400. The charity holds unrestricted reserves of £10,538 and maintains a cash balance of £111,216, with the Trustees confirming no material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
Trustees
- RACHEL Mormanchair
- ALISON WILCOX
- CAROLINE ANDREWS
- Nicola Smart
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £89k | £90k |
| 31/03/2024 | £51k | £16k |
| 31/03/2023 | £51k | £16k |
| 31/03/2022 | £23k | £28k |
| 31/03/2021 | £25k | £14k |
Common questions
Is VERITY THE POLYCYSTIC OVARIES SELF HELP GROUP financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net expenditure of £1,003 for the year, resulting in a decrease in total funds from £97,403 to £96,400. The charity holds unrestricted reserves of £10,538 and maintains a cash balance of £111,216, with the Trustees confirming no material uncertainties regarding its ability to continue as a going concern. Its FY2025 accounts were independently examined.